1
/
of
0
FDA Drug Approval, N018891, CATAPRES-TTS-3
FDA Drug Approval, N018891, CATAPRES-TTS-3
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018891
Company: LAVIPHARM
Drug Name: CATAPRES-TTS-3
Active Ingredients: CLONIDINE
Strength: SYSTEM;TRANSDERMAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: STANDARD
Company: LAVIPHARM
Drug Name: CATAPRES-TTS-3
Active Ingredients: CLONIDINE
Strength: SYSTEM;TRANSDERMAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: STANDARD
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details